Effectiveness of oral acyclovir prophylaxis in renal transplant recipients.
D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D006561:Herpes Simplex / Q000276:immunology / Q000517:prevention & control*; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation
D003524:Cyclosporins; D000212:Acyclovir